Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2010 Apr;55(4):846-8.
doi: 10.1161/HYPERTENSIONAHA.109.148346. Epub 2010 Mar 1.

EP1c times for angiotensin: EP1 receptors facilitate angiotensin II-induced vascular dysfunction

Editorial

EP1c times for angiotensin: EP1 receptors facilitate angiotensin II-induced vascular dysfunction

Ricardo A Pena-Silva et al. Hypertension. 2010 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: No relevant conflict of interest.

Figures

Figure 1
Figure 1
Prostaglandin E2 (PGE2) is a product of metabolism of arachidonic acid (AA) by cyclooxygenase I (COX-1) and the prostaglandin E synthase (PGES), perhaps in microglia. Activation of prostaglandin EP1 receptors by PGE2 on cerebral blood vessels, may increase the intracellular concentrations of calcium (Ca++) or facilitate the activation of regulatory kinases by angiotensin II (Ang II) type I (AT1) receptors, which are required for activation of the NAD(P)H oxidase. Reactive oxygen species (ROS) derived from the active NAD(P)H oxidase, are associated with increased arterial pressure, endothelial dysfunction, and impaired neurovascular coupling.

Comment on

References

    1. Chrissobolis S, Faraci FM. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol Med. 2008;14:495–502. - PMC - PubMed
    1. Capone C, Faraco G, Anrather J, Zhou P, Iadecola C. Cox-1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertension. 2010 current issue. - PMC - PubMed
    1. Yang D, Feletou M, Levens N, Zhang JN, Vanhoutte PM. A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR. Hypertension. 2003;41:143–148. - PubMed
    1. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest. 2002;110:61–69. - PMC - PubMed
    1. Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, Segnani C, Ippolito C, Antonioli L, Blandizzi C, Taddei S, Salvetti A, Del TM. Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension. 2007;49:679–686. - PubMed

MeSH terms